ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
Go back to ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 10.66 -0.2 (1.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.86 | 52 Week High | $2.18 | |||
| Open | $10.67 | 52 Week Low | $0.30 | |||
| Day High | $10.74 | P/E | N/A | |||
| Day Low | $10.62 | EPS | $-3.32 | |||
| Volume | 125,480 | |||||
| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 10.66 -0.2 (1.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.86 | 52 Week High | $2.18 | |||
| Open | $10.67 | 52 Week Low | $0.30 | |||
| Day High | $10.74 | P/E | N/A | |||
| Day Low | $10.62 | EPS | $-3.32 | |||
| Volume | 125,480 | |||||

